Medpace Holdings, Inc. (MEDP) continues to display bullish trend behavior on the daily timeframe, rated as a strong buy across technical indicators and moving averages. The stock has demonstrated robust price appreciation, gaining 6.2% over the past week and 14.2% monthly, amid a yearly advance of 78%. This upward trajectory places MEDP well above its key trendlines, with no immediate signs of reversal. Over the last 30 days, consistent higher highs and higher lows have reinforced the prevailing uptrend, supported by positive momentum across multiple periods.
Traders are monitoring classic pivot points for intraday guidance, with the central pivot at 524.39 acting as a key reference. Immediate support rests at S1 523.03 and S2 521.67, while resistance levels sit at R1 525.75, R2 527.11, and R3 528.47. On a broader scale, the 50-day simple moving average at 513.61 serves as dynamic support, backed by the 100-day MA at 504.55. A deeper retracement could test the 200-day SMA near 482.50, a level that has historically provided buying interest. Upper resistance looms near the all-time high of 628.92, where profit-taking may intensify.
Momentum remains firmly in bullish territory. The Relative Strength Index (RSI) at 62.43 indicates building strength without entering overbought territory, suggesting room for further upside. The MACD line at 3.62 above its signal supports continued positive divergence, aligning with the uptrend. Stochastic (9,6) at 68.98 is in buy mode, though Stochastic RSI at 100 and Williams %R at -8.25 flag short-term overbought conditions that could prompt minor pullbacks. ADX (14) at 29.42 underscores strengthening trend direction.
All moving averages signal buy, with the price decisively above short- and long-term averages. The 5-day SMA stands at 525.37, 20-day at 522.53, and 50-day at 513.61, confirming short-term bullish alignment. Longer-term, the 100-day SMA is 504.55 and 200-day SMA 482.50, both rising and providing confluence for support. Exponential counterparts, such as the 200-day EMA at 494.15, further validate the sustained uptrend structure.
Tickeron’s AI Daily Buy/Sell Signals leverage artificial intelligence to scrutinize vast arrays of market data, technical indicators, and historical price patterns for MEDP. These signals identify potential buy or sell opportunities by recognizing trends, momentum shifts, and recurring chart formations that have proven effective in the past. Traders rely on them to pinpoint entry and exit points, validate ongoing trends, and enhance decision-making processes without emotional bias. Incorporating these AI-driven insights can complement manual chart analysis for more informed trading strategies.
Looking ahead, traders will focus on whether MEDP holds above near-term pivot support at 523 and the 50-day MA near 514 amid any consolidation. A sustained move above R1 526 could target higher pivots and test prior highs. Momentum indicators like RSI and MACD warrant monitoring for divergence, while the alignment of moving averages supports potential trend continuation. Volume confirmation on breakouts remains crucial for validating next moves.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
A.I.dvisor indicates that over the last year, MEDP has been loosely correlated with IQV. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is some statistical probability that if MEDP jumps, then IQV could also see price increases.
| Ticker / NAME | Correlation To MEDP | 1D Price Change % | ||
|---|---|---|---|---|
| MEDP | 100% | -1.63% | ||
| IQV - MEDP | 66% Loosely correlated | +0.22% | ||
| CRL - MEDP | 52% Loosely correlated | -0.29% | ||
| TMO - MEDP | 46% Loosely correlated | -1.33% | ||
| BRKR - MEDP | 43% Loosely correlated | -1.72% | ||
| RVTY - MEDP | 39% Loosely correlated | -1.83% | ||
More | ||||